Zevra Therapeutics, Inc. SEC filings ZVRA

Zevra Therapeutics, Inc. has 870 filings in SEC EDGAR's recent list, going back to May 6, 2008. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 9, 2026 Dec 31, 2025
10-K Annual report Mar 12, 2025 Dec 31, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
10-K Annual report Mar 7, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K Annual report Mar 12, 2021 Dec 31, 2020
10-K/A Amended annual report Apr 8, 2020 Dec 31, 2019
10-K Annual report Feb 28, 2020 Dec 31, 2019
10-K Annual report Mar 1, 2019 Dec 31, 2018
10-K Annual report Mar 30, 2018 Dec 31, 2017
10-K Annual report Mar 10, 2017 Dec 31, 2016
10-K Annual report Mar 16, 2016 Dec 31, 2015

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ZVRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1434647
Former names
KEMPHARM, INC (until Feb 24, 2023); KEMPHARM INC (until Jun 30, 2011)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.